BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38139052)

  • 1. Anti-Aggregative and Protective Effects of Vicenin-2 on Heat and Oxidative Stress-Induced Damage on Protein Structures.
    Patanè GT; Lombardo L; Putaggio S; Tellone E; Ficarra S; Barreca D; Laganà G; De Luca L; Calderaro A
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction and binding of flavonoids to human serum albumin modify its conformation, stability and resistance against aggregation and oxidative injuries.
    Barreca D; Laganà G; Toscano G; Calandra P; Kiselev MA; Lombardo D; Bellocco E
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt B):3531-3539. PubMed ID: 26971858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of Amiloride Binding to Human Serum Albumin: Insights from Thermodynamic, Spectroscopic, and Molecular Docking Investigations.
    Rahman S; Iram S; Rehman MT; Hussain A; Jan AT; Kim J
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deciphering the binding of carbendazim (fungicide) with human serum albumin: A multi-spectroscopic and molecular modelling studies.
    Siddiqui MF; Khan MS; Husain FM; Bano B
    J Biomol Struct Dyn; 2019 Jun; 37(9):2230-2241. PubMed ID: 30047309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of a tyrosine kinase inhibitor, vandetanib with human serum albumin as studied by fluorescence quenching and molecular docking.
    Kabir MZ; Feroz SR; Mukarram AK; Alias Z; Mohamad SB; Tayyab S
    J Biomol Struct Dyn; 2016 Aug; 34(8):1693-704. PubMed ID: 26331959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectroscopic and molecular modeling approaches to investigate the binding of proton pump inhibitors to human serum albumin.
    Pawar SK; Punith R; Naik RS; Seetharamappa J
    J Biomol Struct Dyn; 2017 Nov; 35(15):3205-3220. PubMed ID: 27771990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the combination characteristics of lumefantrine, an antimalarial drug and human serum albumin through spectroscopic and molecular docking studies.
    Musa KA; Ridzwan NFW; Mohamad SB; Tayyab S
    J Biomol Struct Dyn; 2021 Feb; 39(2):691-702. PubMed ID: 31913089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of novel Aurora kinase inhibitor MK-0457 with human serum albumin: Insights into the dynamic behavior, binding mechanism, conformation and esterase activity of human serum albumin.
    Yang H; Zeng Q; He Z; Wu D; Li H
    J Pharm Biomed Anal; 2020 Jan; 178():112962. PubMed ID: 31711864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectroscopic and Molecular Docking Study on Specific Binding and Inhibition of Isoniazid to Human Serum Albumin and Catalase.
    Wang YR; Fang Q; Hu TY; Liu Y
    Guang Pu Xue Yu Guang Pu Fen Xi; 2016 Nov; 36(11):3789-95. PubMed ID: 30226718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveiling interaction mechanisms between myricitrin and human serum albumin: Insights from multi-spectroscopic, molecular docking and molecular dynamic simulation analyses.
    Niu T; Zhu X; Zhao D; Li H; Yan P; Zhao L; Zhang W; Zhao P; Mao B
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 Jan; 285():121871. PubMed ID: 36155929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multispectroscopic and molecular modeling approach to investigate the interaction of flavokawain B with human serum albumin.
    Feroz SR; Mohamad SB; Bujang N; Malek SN; Tayyab S
    J Agric Food Chem; 2012 Jun; 60(23):5899-908. PubMed ID: 22624666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of sulfasalazine-bovine serum albumin and human serum albumin interaction by spectroscopic and theoretical approach.
    Rahman N; Khalil N
    Spectrochim Acta A Mol Biomol Spectrosc; 2023 Nov; 300():122865. PubMed ID: 37269654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomolecular interaction mechanism of an anticancer drug, pazopanib with human serum albumin: a multi-spectroscopic and computational approach.
    Kandandapani S; Kabir MZ; Ridzwan NFW; Mohamad SB; Tayyab S
    J Biomol Struct Dyn; 2022 Nov; 40(18):8312-8323. PubMed ID: 33870854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of an anticancer drug, axitinib to human serum albumin: Fluorescence quenching and molecular docking study.
    Tayyab S; Izzudin MM; Kabir MZ; Feroz SR; Tee WV; Mohamad SB; Alias Z
    J Photochem Photobiol B; 2016 Sep; 162():386-394. PubMed ID: 27424099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probing the mechanism of interaction of metoprolol succinate with human serum albumin by spectroscopic and molecular docking analysis.
    Pawar SK; Jaldappagari S
    Luminescence; 2017 Sep; 32(6):942-951. PubMed ID: 28233399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multispectroscopic insight, morphological analysis and molecular docking studies of Cu
    Yousuf I; Bashir M; Arjmand F; Tabassum S
    J Biomol Struct Dyn; 2019 Aug; 37(12):3290-3304. PubMed ID: 30124142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular interaction study of an anticancer drug, ponatinib with human serum albumin using spectroscopic and molecular docking methods.
    Tayyab S; Sam SE; Kabir MZ; Ridzwan NFW; Mohamad SB
    Spectrochim Acta A Mol Biomol Spectrosc; 2019 May; 214():199-206. PubMed ID: 30780089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination mode of antimalarial drug mefloquine and human serum albumin: Insights from spectroscopic and docking approaches.
    Musa KA; Ridzwan NFW; Mohamad SB; Tayyab S
    Biopolymers; 2020 Feb; 111(2):e23337. PubMed ID: 31691964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycation reduces the binding dynamics of aflatoxin B
    Qureshi MA; Amir M; Khan RH; Musarrat J; Javed S
    J Biomol Struct Dyn; 2023; 41(24):14797-14811. PubMed ID: 37021366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactive association between RhoA transcriptional signaling inhibitor, CCG1423 and human serum albumin: Biophysical and in silico studies.
    Kabir MZ; Ghani H; Mohamad SB; Alias Z; Tayyab S
    J Biomol Struct Dyn; 2018 Aug; 36(10):2495-2507. PubMed ID: 28749242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.